Display options
Share it on

Internist (Berl). 2017 Apr;58(4):344-353. doi: 10.1007/s00108-017-0200-9.

[Multimorbidity management and the physician's daily clinical dilemma].

Der Internist

[Article in German]
E Battegay, M Cheetham, B M Holzer, A Nowak, D Schmidt, S Rampini

Affiliations

  1. Klinik und Poliklinik für Innere Medizin, UniversitätsSpital Zürich, Rämistr. 100, 8091, Zürich, Schweiz. [email protected].
  2. Kompetenzzentrum Multimorbidität, Universität Zürich, Zürich, Schweiz. [email protected].
  3. Forschungsschwerpunkt Dynamics of Healthy Aging, Universität Zürich, Zürich, Schweiz. [email protected].
  4. Klinik und Poliklinik für Innere Medizin, UniversitätsSpital Zürich, Rämistr. 100, 8091, Zürich, Schweiz.
  5. Kompetenzzentrum Multimorbidität, Universität Zürich, Zürich, Schweiz.
  6. Forschungsschwerpunkt Dynamics of Healthy Aging, Universität Zürich, Zürich, Schweiz.

PMID: 28246687 DOI: 10.1007/s00108-017-0200-9

Abstract

About 20-25% of all persons and about 90% of all patients who are acutely hospitalized in internal medicine departments have multiple acute or chronic diseases. They are multimorbid. The encounter with multimorbid patients has become the most common situation in the health care system. Theoretically, multimorbidity results in an innumerable potential disease constellations. In addition, the likelihood of interactions between diseases (disease-disease interactions, DDI) and the complexity increases overproportionately with each additional disease. However, multimorbidity often occurs in typical diadic, triadic, or higher characteristic combinations, in "disease clusters", e. g., vascular risk factors, heart and lung diseases, Frailty and dementia, psychiatric and somatic disorders. Such combinations lead to a worsening of the overall prognosis. In addition, DDIs are often difficult to treat or are life-threatening. Examples of DDIs include the following: anticoagulation and simultaneous severe bleeding, pain treatment and hypertension or renal insufficiency, depression and reduced medication adherence, chronic obstructive pulmonary disease and depression, Frailty and neurodepressant drugs and frequent falls, and combined psychiatric and somatic disorders. Such DDIs are common. Nevertheless, there are few studies and clinical guidelines that address these issues. The care of multimorbid patients is, therefore, heavily reliant upon guidelines developed mostly for single diseases. However, multimorbidity and serious DDIs are usually not addressed in these. Clinical guidelines can thus inadvertently jeopardize the safety of persons suffering from multiple diseases. In addition, stressful dilemmas arise for physicians encountering DDIs because of difficult treatment decisions.

Keywords: Anticoagulants; Disease–disease interactions; Hemorrhage; Hypertension; Pain, drug therapy

References

  1. BMC Med Inform Decis Mak. 2016 Oct 18;16(1):133 - PubMed
  2. Br J Clin Pharmacol. 2013 Jun;75(6):1396-405 - PubMed
  3. J Am Geriatr Soc. 2009 Feb;57(2):225-30 - PubMed
  4. Medicine (Baltimore). 2017 Feb;96(8):e6144 - PubMed
  5. Ann Nutr Metab. 2014;65(4):324-32 - PubMed
  6. Lancet. 2012 Jul 7;380(9836):37-43 - PubMed
  7. J Clin Epidemiol. 2014 Nov;67(11):1242-50 - PubMed
  8. J Thorac Dis. 2014 Nov;6(11):1615-31 - PubMed
  9. Psychosomatics. 2000 Nov-Dec;41(6):465-71 - PubMed
  10. Swiss Med Wkly. 2012 Mar 09;142:w13533 - PubMed
  11. PLoS One. 2014 Oct 13;9(10):e110309 - PubMed
  12. Med Care. 2003 Nov;41(11):1284-92 - PubMed
  13. PLoS One. 2017 Jan 3;12 (1):e0168987 - PubMed
  14. J Am Med Dir Assoc. 2013 May;14(5):319-25 - PubMed
  15. Eur Heart J. 2016 Oct 7;37(38):2893-2962 - PubMed
  16. BMC Public Health. 2011 Feb 14;11:101 - PubMed
  17. BMJ. 2012 Oct 04;345:e6341 - PubMed
  18. Diabet Med. 2005 Jan;22(1):107-9 - PubMed
  19. BMJ. 2014 Jan 30;348:g445 - PubMed
  20. Medicine (Baltimore). 2015 Jan;94(1):e377 - PubMed
  21. BMJ. 2012 Sep 03;345:e5205 - PubMed

MeSH terms

Publication Types